SCHEMBL10939643

SCHEMBL10939643

Cc1ccc(CN)c(Cl)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.37
PNMT P11086 2/20 0.37
PDCD1LG2 Q9BQ51 2/20 0.36
CD274 Q9NZQ7 2/20 0.36
CCR1 P32246 1/20 0.36
RAB9A P51151 1/20 0.36
CCR5 P51681 1/20 0.36
KMT2A Q03164 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
NOTUM Q6P988 1/20 0.34
KDM4E B2RXH2 2/20 0.32
ALDH1A1 P00352 1/20 0.32
DPP4 P27487 1/20 0.32
NOS3 P29474 1/20 0.32
NOS2 P35228 1/20 0.32
HTT P42858 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
MAPT P10636 1/20 0.32
LMNA P02545 1/20 0.31
CASP6 P55212 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5013615 0.98 POLB (0.36) POLBPNMTPDCD1LG2CD274CCR1
SCHEMBL3433107 0.80 KMT2A (0.47) CCR1RAB9ACCR5KMT2ANPSR1
SCHEMBL9181886 0.80 CTRC (0.38) POLBCCR1RAB9ACCR5KMT2A
SCHEMBL24094560 0.78 CCR1 (0.36) CCR1RAB9ACCR5KMT2ANPSR1
SCHEMBL31139119 0.78 ALDH1A1 (0.45) POLBCCR1RAB9ACCR5KMT2A
SCHEMBL6320237 0.78 ALDH1A1 (0.45) POLBCCR1RAB9ACCR5KMT2A
SCHEMBL7083846 0.77 CD274 (0.41) PNMTPDCD1LG2CD274KMT2ANOTUM
SCHEMBL4325085 0.77 CCR1 (0.39) POLBPNMTPDCD1LG2CD274CCR1
SCHEMBL10483898 0.76 CD274 (0.39) PDCD1LG2CD274KMT2AHTTMAPT
SCHEMBL8325450 0.75 TUBB4A (0.40) CCR1RAB9ACCR5KMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130079373-A1 Substituted Methanesulfonamide Derivatives as Vanilloid Receptor Ligands GRUENENTHAL GMBH (DE) 2013-03-28 US disclosed
US-4499097-A HYPOTENSIVE AGENTS AMERICAN CYANAMID COMPANY (US) 1985-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130079373-A1 Substituted Methanesulfonamide Derivatives as Vanilloid Receptor Ligands TRPV1, TRPV3, TRPA1 POLB 4720/4885PNMT 680/4885PDCD1LG2 3353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.